Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. Transition Agreement with Mr. Kurada On January 11, 2024, Heliogen, Inc. (the “Company”) and Sagar Kurada entered into a transition agreement (the “Transition Agreement”), pursuant to which the Company and Mr. Kurada mutually agreed that Mr. Kurada will cease to serve as Chief Financial Officer and Head of Strategy of the Company, effective January 11, 2024, and will cease employment with the Company, effective January 31, 2024 (the “Separation Date”). The Transition Agreement provides that Mr. Kurada will continue to receive his base salary and benefits eligibility through the Separation Date. Mr. Kurada will not receive a bonus for 2023. Subject to Mr. Kurada’s continued employment through the Separation Date, his execution and non-revocation of a general release of claims in favor of the Company, his compliance with his existing confidentiality obligations and the non-disparagement and other terms of the Transition Agreement, and his continued support to the Company with the orderly transition of his work, Mr. Kurada will receive (i) payments equal to his base salary for two months following the Separation Date; and (ii) payment of his and his dependents’ healthcare premiums pursuant to the Consolidated Omnibus Budget Reconciliation Act for a period of up to two months after the Separation Date. All equity awards granted to Mr. Kurada will be unvested as of the Separation Date and will therefore be canceled. The Transition Agreement is attached hereto as